This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Cancer-Associated Thrombosis
  • /
  • Apixaban for the Prevention of Venous Thromboembol...
Clinical trial

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (AVERT)

Read time: 2 mins
Last updated:19th Nov 2018
Status: Completed
Identifier: NCT02048865
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest